These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10857998)

  • 1. A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339).
    Macdonald JS; Jacobson JL; Ketchel SJ; Weiss G; Taylor S; Mills G; Kuebler JP; Rivkin S; Conrad M
    Invest New Drugs; 2000 May; 18(2):199-202. PubMed ID: 10857998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241).
    Macdonald JS; Benedetti JK; Modiano M; Alberts DS
    Invest New Drugs; 1997; 15(4):357-9. PubMed ID: 9547679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of topotecan in advanced gastric cancer: a Southwest Oncology Group study.
    Benedetti JK; Burris HA; Balcerzak SP; Macdonald JS
    Invest New Drugs; 1997; 15(3):261-4. PubMed ID: 9387050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of topotecan in the treatment of metastatic or recurrent squamous carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (E3393).
    Murphy BA; Leong T; Burkey B; Langer C; Forastiere A
    Am J Clin Oncol; 2001 Feb; 24(1):64-6. PubMed ID: 11232952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.
    Stevenson JP; Scher RM; Kosierowski R; Fox SC; Simmonds M; Yao KS; Green F; Broom C; Fields SZ; Krebs JB; O'Dwyer PJ
    Eur J Cancer; 1998 Aug; 34(9):1358-62. PubMed ID: 9849417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer.
    Lorusso D; Mainenti S; Pietragalla A; Fusco E; Malaguti P; Masciullo V; Scambia G
    Oncology; 2011; 80(5-6):390-4. PubMed ID: 21829040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
    Bookman MA; Blessing JA; Hanjani P; Herzog TJ; Andersen WA
    Gynecol Oncol; 2000 Jun; 77(3):446-9. PubMed ID: 10831357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293).
    Asbury RF; Lipsitz S; Graham D; Falkson CI; Baez L; Benson AB
    Am J Clin Oncol; 2000 Feb; 23(1):45-6. PubMed ID: 10683076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group.
    Hochster H; Wadler S; Runowicz C; Liebes L; Cohen H; Wallach R; Sorich J; Taubes B; Speyer J
    J Clin Oncol; 1999 Aug; 17(8):2553-61. PubMed ID: 10561322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group study.
    Wall JG; Benedetti JK; O'Rourke MA; Natale RB; Macdonald JS
    Invest New Drugs; 1997; 15(3):257-60. PubMed ID: 9387049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
    Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Muderspach LI; Blessing JA; Levenback C; Moore JL
    Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.
    Budd GT; Rankin C; Hutchins LF; Wong L; Petruska PJ; Antman K;
    Invest New Drugs; 2002 Feb; 20(1):129-32. PubMed ID: 12003189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.
    Seiden MV; Ng SW; Supko JG; Ryan DP; Clark JW; Lynch T; Huang KC; Kwiatkowski D; Skarin A; Eder JP
    Clin Cancer Res; 2002 Mar; 8(3):691-7. PubMed ID: 11895897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
    Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
    Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of oral topotecan in advanced non-small cell lung cancer.
    White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
    Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacologic study of weekly bolus topotecan for advanced non-small-cell lung cancer.
    Masuda N; Matsui K; Negoro S; Takeda K; Kudoh S; Nakagawa K; Mukaiyama A; Arase H; Yoshida P; Ijima T; Takada M; Fukuoka M
    Clin Lung Cancer; 2010 Jul; 11(4):271-9. PubMed ID: 20630830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.